Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors

Details Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors

2011-02-15

2011-02-15

Andres, Janet L. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S112000

Reexamination Certificate

active

07888508

ABSTRACT:
Compounds which are pyrrolo[2,3-b]pyridine derivatives or pharmaceutically acceptable salts thereof, their preparation process and pharmaceutical compositions comprising them are disclosed; these compounds are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders; also disclosed is a process under SPS conditions for preparing the compounds of the invention and chemical libraries comprising a plurality of them.

REFERENCES:
patent: 3320268 (1967-05-01), Shen et al.
patent: 5663346 (1997-09-01), Buzzetti et al.
patent: 6476034 (2002-11-01), Wang et al.
patent: 6632819 (2003-10-01), Wang et al.
patent: WO 95/28400 (1995-10-01), None
patent: WO 96/11929 (1996-04-01), None
patent: WO 97/03069 (1997-01-01), None
patent: WO 98/50364 (1998-11-01), None
patent: WO 99/32111 (1999-07-01), None
patent: WO 99/37637 (1999-07-01), None
patent: WO 99/58496 (1999-11-01), None
patent: WO 00/21950 (2000-04-01), None
patent: WO 00/21951 (2000-04-01), None
patent: WO 00/24717 (2000-05-01), None
patent: WO 00/71537 (2000-11-01), None
patent: WO 01/01986 (2001-01-01), None
patent: WO 01/58869 (2001-08-01), None
patent: WO 01/98299 (2001-12-01), None
patent: WO 03/082868 (2003-10-01), None
Ferreira P.M.T. et al., “Synthesis of β-Substituted AlaninesviaMichael Addition of Nucleophiles to Dehydroalanine Derivatives”,J. Chem. Soc., Perkin Trans. I, 19:3317-3324 (2000).
Rolland-Fulcrand V. et al., “Efficient Chemoenzymatic Synthesis of Enantiomerically Pure β-Heterocyclic Amino Acid Derivatives”,Tetrahedron Asymmetry11:4719-4724 (2000).
Fivush A.M. et al., “AMEBA: An Acid Sensitive Aldehyde Resin for Solid Phase Synthesis”,Tetrahedron Letters38(41):7151-7154 (1997).
Jensen K.J. et al., “Backbone Amide Linker (BAL) Strategy for Solid-Phase Synthesis of C-Terminal-Modified and Cyclic Peptides”,J. Am. Chem. Soc. 120(22):5441-5452 (1998).
Alsina J. et al., “Solid-Phase Synthesis with Tris(alkoxy)benzyl Backbone Amide Linkage (BAL)”,Chem. Eur. J. 5(10):2787-2795 (1999).
Palmer B.D. et al., “Structure-Activity Relationships for 5-Substituted l-Phenylbenzimidazoles as Selective Inhibitors of the Platelet-Derived Growth Factor Receptor”,J. Med, Chem. 42(13):2373-2382 (1999).
Lackey K. et al., “The Discovery of Potent cRaf1 Kinase Inhibitors”,Bioorganic&Medicinal Chemistry Letters10:223-226 (2000).
Cohen P., “The Development and Therapeutic Potential of Protein Kinase Inhibitors”,Current Opinion in Chemical Biology3:459-465 (1999).
Hosoi T. et al., “Evidence for CdkS as a Major Activity Phosphorylating Tau Protein in Porcine Brain Extract”,J. Biochem. 117(4):741-749 (1995).
Schneller S.W. et al., “Synthesis of 4-Amino-1H-Pyrrolo[2,3-b]Pyridine (1,7-Dideazaadenine) and 1H-Pyrrolo[2,3-b]Pyridin-4-ol (1,7-Dideazahypoxanthine)”,Journal of Organic Chemistry45(20):4045-4048 (1980), Chemical Abstracts C.A. 93:168162.
Brodrick A. et al., “1H-Pyrrolo[2,3-b]Pyridines. Part III. A Novel Synthetic Route from 1-Substituted 2-Aminopyrroles”,J.C.S. Perkin Trans. I: Organic and Bio-Organic Chemistry19:1910-1913 (1975).
Levacher V. et al., “One Pot Synthesis of Pyrrolo[2,3-b]Pyridine Derivatives”,Synthetic Communications24(19):2697-2705 (1994).
Allegretti M. et al., “A Practical Synthesis of 7-Azaindolylcarboxy-Endo-Tropanamide (DF 1012)”,Organic Process Research&Development7(2):209-213 (2003).
Huang X. et al., “Expanding Pd-Catalyzed C-N Bond-Forming Processes: The First Amidation of Aryl Sulfonates, Aqueous Amination, and Complementarity with Cu-Catalyzed Reactions”,J. Am. Chem. Soc. 125(22):6653-6655 (2003).
Ali M.H. et al, “An Improved Method for the Palladium-Catalyzed Amination of Aryl Iodides”,J. Org. Chem. 66(8):2560-2565 (2001).
Kuwano R. et al., “Aqueous Hydroxide as a Base for Palladium-Catalyzed Amination of Aryl Chlorides and Bromides”,J. Org. Chem. 67(18):6479-6486 (2002).

Affiliated with

Also associated with

Rating

Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolo[2,3-B]pyridine derivatives active as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2640753